What Fueled The Previous Growth In The Bartonellosis Market?
The bartonellosis market has seen considerable growth due to a variety of factors.
• Recent years have witnessed a swift rise in the growth of the Bartonellosis market. The market is expected to escalate from a value of $1.17 billion in 2024 to an estimated worth of $1.31 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.0%.
The unprecedented growth during this historic period is directly linked to factors such as heightened occurrences of the Bartonella disease, an increase in healthcare spending, more commitment towards research and development funding, an increased incidence of transferable diseases, and an heightened prevalence of infectious diseases.
What Can Be Expected from the Bartonellosis Market Size Evolve over the Forecast Period?
The bartonellosis market is expected to maintain its strong growth trajectory in upcoming years.
• Expected to witness fast-paced expansion in the upcoming years, the bartonellosis market is estimated to reach $2.03 billion by 2029 with an impressive CAGR of 11.7%.
This growth during the forecasted period can be credited to factors such as increased cases of zoonotic diseases, augmented disease consciousness, a growing population of pet owners, increased focus on individualized medicine, and rising awareness about cat scratch disease. Key trends in this period will include progress in medical technology and biotechnology, the introduction of combined testing, enhancements in diagnostic methods, and continuous research and development.
Which Key Drivers Are Propelling The Bartonellosis Market's Growth?
An increase in zoonotic disease incidents, which are illnesses transmitted from animals to humans, either directly or via vectors, is set to boost the bartonellosis market's expansion. Multiple factors such as heightened contact between humans and animals, environmental changes, deforestation, global travel, and cross-species pathogen transmission contribute to the frequency of zoonotic diseases. Bartonellosis contributes to these occurrences, demonstrating how humans can be infected by bacterial pathogens carried by animal vectors like fleas, ticks, and lice. This disease, with its range of clinical presentations, underscores the significance of understanding how vector-borne diseases are transmitted concerning public health. For example, a report by the Government of Canada in January 2023 revealed that the number of submitted rabies samples rose to 159 in November 2022 from 135 in October 2022. Consequently, it can be inferred that an increase in zoonotic diseases is propelling the growth of the bartonellosis market.
How Is The Bartonellosis Market segmented?
The bartonellosis market covered in this report is segmented –
1) By Disease Type: Cat Scratch Disease (CSD), Trench Fever, Bartonella Endocarditis, Other Disease Types
2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing, Serological Testing, Culture Methods, Histological Testing
3) By Treatment: Antibiotics, Antibacterial Agents, Supportive Care
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users
Subsegments:
1) By Cat Scratch Disease (CSD): Immunocompetent Hosts, Immunocompromised Hosts, Neurological Complications
2) By Trench Fever: Acute Trench Fever, Chronic Trench Fever, Asymptomatic Infections
3) By Bartonella Endocarditis: Native Valve Endocarditis, Prosthetic Valve Endocarditis, Bloodstream Infections
4) By Other Disease Types: Bacillary Angiomatosis, Parinaud’s Oculoglandular Syndrome, Bartonella-associated Vasculitis
Pre-Book The Bartonellosis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Bartonellosis Market?
Key players in the bartonellosis market are channeling their efforts towards raising funds in order to facilitate early diagnosis and broaden treatment alternatives for this disease. These fundraising endeavors are meant to generate resources that will aid the research, intervention, and prevention of bartonellosis, and are instrumental in fostering innovation and ensuring better accessibility to healthcare remedies. For instance, in April 2022, the Global Lyme Alliance (GLA), a nonprofit organization based in the US, kick-started a crowdfunding drive with the aim of collecting $300,000 to fund innovative research on Bartonella, an obscure pathogen that can lead to severe health complications like neuroinflammation and psychiatric disorders. This campaign was timed to coincide with Lyme disease awareness month and is aimed at improving our grasp on how Bartonella operates in the human body - a crucial aspect for devising more potent cures for Bartonella infections and associated diseases like Lyme disease. The campaign underscores the call for heightened awareness and more funding to assist those grappling with these incapacitating diseases.
Who Are the Key Players In The Bartonellosis Market?
Major companies operating in the bartonellosis market are:
• Mayo Clinic Laboratories
• Northwell Health Labs
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• IDEXX Laboratories Inc.
• Bio-Rad Laboratories Inc.
• Alberta Precision Laboratories
• Jiangsu BioPerfectus Technologies Co. Ltd.
• ARUP Laboratories
• Surmodics Inc.
• Medical Diagnostic Laboratories LLC
• Creative Biolabs
• IGeneX Inc.
• Karius Inc.
• Synnovis Group LLP
• Galaxy Diagnostics Inc.
• Gold Standard Diagnostics
• Eurofins Biomnis
• AMMAGENOMICS Private Limited
• Ringbio
What Is The Most Dominant Region In The Bartonellosis Market?
North America was the largest region in the bartonellosis market in 2024. The regions covered in the bartonellosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
